CLINICAL ROLE -
A Novel Therapeutic Option for the Management of R/R FL
Mosunetuzumab-axgb may be better tolerated by older adults with relapsed or refractory follicular lymphoma and patients with poor performance status.
Read More
Small Molecule Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
Importantly, when considering the useof small molecule inhibitors, potential drug interactions must be evaluated.